Search

Author/Creator Deniz, Yamo

1. 166 Efficacy of Dupilumab in Children With Uncontrolled, Moderate-to-Severe Type 2 Asthma, With and Without Evidence of Allergy Enrolled in Phase 3 VOYAGE. (11th October 2021)

Authors:
Szefler, Stanley J; Bacharier, Leonard B; Maspero, Jorge F; Papadopoulos, Nikos; Domingo, Christian; Daizadeh, Nadia; Lederer, David J; Hardin, Megan; Jacob-Nara, Juby A; Deniz, Yamo; Gall, Rebecca; Ortiz, Benjamin; Djandji, Michel; Rowe, Paul J
Journal:
Archives of disease in childhood
Issue:
Volume 106(2021)Supplement 2
Page Start:
A70
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 230. ENDOSCOPIC REFERENCE SCORE REMODELING SUBSCORE AND ESOPHAGEAL EOSINOPHIL COUNT DO NOT CORRELATE IN PLACEBO-TREATED EOSINOPHILIC ESOPHAGITIS PATIENTS FROM DUPILUMAB STUDIES. (24th September 2022)

Authors:
Hirano, Ikuo; Rothenberg, Marc E; Spergel, Johnathan M; Aceves, Seema; Greenhawt, Matthew; Schoepfer, Alain M; Philpott, Hamish; Chen, Zhen; Radwan, Amr; Khodzhayev, Angela; Deniz, Yamo; Rowe, Paul J; Pela, Tiffany; Jacob-Nara, Juby A
Journal:
Diseases of the esophagus
Issue:
Volume 35(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 233. ENDOSCOPIC REFERENCE SCORE AND HISTOLOGICAL SCORING SYSTEM ARE COMPLEMENTARY ASSESSMENTS FOR CHARACTERIZING FIBROSTENOTIC OR INFLAMMATORY PHENOTYPES IN EOSINOPHILIC ESOPHAGITIS PATIENTS. (24th September 2022)

Authors:
Collins, Margaret H; Rothenberg, Marc E; Bredenoord, Albert J; Wechsler, Joshua; Chehade, Mirna; Philpott, Hamish; Chen, Zhen; Radwan, Amr; Pela, Tiffany; Khodzhayev, Angela; Jacob-Nara, Juby A; Deniz, Yamo; Rowe, Paul J
Journal:
Diseases of the esophagus
Issue:
Volume 35(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps. Issue 4 (28th November 2022)

Authors:
Siddiqui, Shahid; Bachert, Claus; Chaker, Adam M.; Han, Joseph K.; Hellings, Peter W.; Peters, Anju T.; Heffler, Enrico; Kamat, Siddhesh; Zhang, Haixin; Nash, Scott; Khan, Asif H.; De Prado Gomez, Lucia; Jacob-Nara, Juby A.; Rowe, Paul J.; Deniz, Yamo
Journal:
ERJ open research
Issue:
Volume 8:Issue 4(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Issue 10 (October 2021)

Authors:
Busse, William W; Wenzel, Sally E; Casale, Thomas B; FitzGerald, J Mark; Rice, Megan S; Daizadeh, Nadia; Deniz, Yamo; Patel, Naimish; Harel, Sivan; Rowe, Paul J; Graham, Neil M H; O'Riordan, Thomas; Pavord, Ian D
Journal:
Lancet
Issue:
Volume 9:Issue 10(2021)
Page Start:
1165
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials. Issue 9 (31st January 2022)

Authors:
Bachert, Claus; Corren, Jonathan; Lee, Stella E.; Zhang, Haixin; Harel, Sivan; Cunoosamy, Danen; Khan, Asif H.; Jacob‐Nara, Juby A.; Siddiqui, Shahid; Nash, Scott; Rowe, Paul J.; Deniz, Yamo
Journal:
International forum of allergy & rhinology
Issue:
Volume 12:Issue 9(2022)
Page Start:
1191
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study. (4th May 2023)

Authors:
Maspero, Jorge F.; Cardona, Guido; Schonffeldt, Patricia; Tolcachier, Alberto; González-Diaz, Sandra N.; Yañez, Anahi; Galvao, Clovis E.; Msihid, Jerome; Gall, Rebecca; Siddiqui, Shahid; Rowe, Paul J.; Deniz, Yamo; Jacob-Nara, Juby A.; Djandji, Michel
Journal:
Journal of asthma
Issue:
Volume 60:Number 5(2023)
Page Start:
981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL−1. Issue 6 (23rd June 2022)

Authors:
Rabe, Klaus F.; Pavord, Ian D.; Castro, Mario; Wechsler, Michael E.; Daizadeh, Nadia; Kapoor, Upender; Ortiz, Benjamin; Radwan, Amr; Johnson, Robert R.; Rowe, Paul J.; Deniz, Yamo; Jacob-Nara, Juby A.
Journal:
European respiratory journal
Issue:
Volume 59:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status. Issue 1 (4th June 2021)

Authors:
Fujieda, Shigeharu; Matsune, Shoji; Takeno, Sachio; Ohta, Nobuo; Asako, Mikiya; Bachert, Claus; Inoue, Tomoyuki; Takahashi, Yoshinori; Fujita, Hiroyuki; Deniz, Yamo; Rowe, Paul; Ortiz, Benjamin; Li, Yongtao; Mannent, Leda P.
Journal:
Allergy
Issue:
Volume 77:Issue 1(2022)
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗